Job description


  • Entry level
  • No Education
  • Salary to negotiate
  • Pleasanton


The Global Market Access Associate position is based at the Roche Molecular Diagnostics Headquarter in Pleasanton, California. The candidate will have responsibility for identification and demonstration of value propositions as well as oversee global reimbursement strategies, health economics and outcomes research (HEOR) and market access initiatives to secure access for products in the Roche Molecular Diagnostics portfolio. 
Key Responsibilities:
The key responsibilities can be grouped into three major areas: (1) Maintain product and therapeutic disease area expertise to identify and develop value propositions (2) Work cross-functionally and with global Affiliates to develop and deliver market access / reimbursement strategies and deliverables (3) Develop and execute health economics and outcomes research (HEOR) studies to support global market access strategies.
Demonstrate and maintain knowledge of established and emerging infectious diseases and the scientific, clinical and commercial developments in the field of infectious disease diagnostics, antibiotic susceptibility testing, hospital infection control. 
Leverage the product and therapeutic disease area knowledge to develop targeted value propositions and communication tools describing the product value story (e.g. global value dossier, scientific publications). 
Act as single point of market access expertise for the assigned portfolio and collaborate closely with the relevant functions (e.g. Commercial, Regulatory, Legal, Medical Affairs, etc.) to align on market access / reimbursement strategies and deliverables.
Collaborate with global colleagues to support market access initiatives and execution of plan. 
Support the education of internal stakeholders on dynamics, trends, and policy changes related to reimbursement, market access, and HEOR practices. 
Identify and integrate parameters into clinical trial programs necessary to demonstrate clinical, economic, and humanistic product value to payers and other key decision-makers. Formulate and execute HEOR studies (e.g. retrospective claims analysis, cost analyses, etc.) to differentiate and demonstrate the value of Roche Molecular Diagnostic products. Effectively communicate HEOR study findings via abstracts and/or scientific manuscripts. 
Impact on the Organization:  Achieve and maintain patient access for Roche Molecular Diagnostic products by demonstrating and communicating product value to payers and other key stakeholders.
Education: Undergraduate and graduate degree in relevant field(s) required.  One degree must be in relevant scientific / clinical field (e.g. Microbiology, Molecular / Cellular Biology, Bioengineering, PharmD, MD, etc.).  The other degree must be in health economics / economics or health policy – related discipline.  
Experience: No professional experience in Market Access is required. Educational requirements are mandatory. 
Knowledge, Skills, Abilities:
Solid understanding of infectious diseases, antibiotic resistance.  Ability to understand and interpret scientific literature
Solid understanding of health economics and outcomes (HEOR) research concepts and methodologies
Strong data analytic capabilities including familiarity with advanced biostatistics / epidemiology / health services research methods
Intermediate to Advanced working knowledge of Microsoft Excel
Strong technical writing and effective communication skills; previous publication experience a plus
Collaborative mindset and team-player – ability to work well cross-functionally and across culturally diverse stakeholders
Detail oriented, strong project management skills
Self-motivated and independent, strategic thinker
Fluent written and oral English; additional language skills a plus

About the company

Roche is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange.

The company headquarters are located in Basel and the company has many pharmaceutical and diagnostic sites around the world – including: Tucson, AZ; Pleasanton, CA; Vacaville, California, Oceanside, California, Branchburg, NJ; Indianapolis, Indiana; Florence, South Carolina; and Ponce, Puerto Rico in the US; Welwyn Garden City and Burgess Hill in the UK; Clarecastle in Ireland; Mannheim and Penzberg in Germany; Mississauga and Laval in Canada; Shanghai in China; Mumbai & Hyderabad in India; São Paulo and Rio de Janeiro, Brazil; Segrate, Milan in Italy; Johannesburg in South Africa; Karachi, Islamabad and Lahore in Pakistan. There are 26 manufacturing sites worldwide.

Companies in this sector